X/T+X-EC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for X/T+X-EC, covering 2025-10-08 to 2025-10-08. Get the full timeline:
Most recent: Clinical Trial Update: The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab. [Phase 2]